Regulatory effect of IL-38 on NF-κB pathway in systemic lupus erythematosus.

[1]  C. Pitzalis,et al.  IL-36, IL-37, and IL-38 Cytokines in Skin and Joint Inflammation: A Comprehensive Review of Their Therapeutic Potential , 2019, International journal of molecular sciences.

[2]  R. Vierstra,et al.  To save or degrade: balancing proteasome homeostasis to maximize cell survival , 2018, Autophagy.

[3]  Kazuhiko Matsumoto,et al.  Analysis of serum IL-38 in juvenile-onset systemic lupus erythematosus , 2018, Modern rheumatology.

[4]  Jie Dong,et al.  In vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)/lpr mice. , 2017, Immunobiology.

[5]  E. Morand,et al.  Brief Report: Interleukin‐38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus , 2015, Arthritis & rheumatology.

[6]  T. Saitoh,et al.  Autophagy and autophagy-related proteins in the immune system , 2015, Nature Immunology.

[7]  Xianli Yuan,et al.  Role of IL-38 and Its Related Cytokines in Inflammation , 2015, Mediators of inflammation.

[8]  C. Garlanda,et al.  TIR8/SIGIRR is an Interleukin-1 Receptor/Toll Like Receptor Family Member with Regulatory Functions in Inflammation and Immunity , 2012, Front. Immun..

[9]  P. Barrow,et al.  Expression of IL‐1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL‐1F8 and IL‐1F9 , 2012, European journal of immunology.

[10]  L. Joosten,et al.  IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist , 2012, Proceedings of the National Academy of Sciences.

[11]  L. Rönnblom,et al.  The type I interferon system in the development of lupus. , 2011, Seminars in immunology.

[12]  Vaishali R. Moulton,et al.  Abnormalities of T cell signaling in systemic lupus erythematosus , 2011, Arthritis research & therapy.

[13]  L. Joosten,et al.  IL-1 family nomenclature , 2010, Nature Immunology.

[14]  Lu Huang,et al.  Update of TTD: Therapeutic Target Database , 2009, Nucleic Acids Res..

[15]  M. Karin,et al.  Regulation and function of NF-kappaB transcription factors in the immune system. , 2009, Annual review of immunology.

[16]  M. Krumbholz,et al.  B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation , 2006, Annals of neurology.

[17]  C. Lau,et al.  Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide. , 2006, The American journal of medicine.

[18]  R. Sinniah,et al.  In situ glomerular expression of activated NF-κB in human lupus nephritis and other non-proliferative proteinuric glomerulopathy , 2006, Virchows Archiv.

[19]  J. Anaya,et al.  Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective? , 2004, Seminars in arthritis and rheumatism.

[20]  J. Sims,et al.  Interleukin (IL)-1F6, IL-1F8, and IL-1F9 Signal through IL-1Rrp2 and IL-1RAcP to Activate the Pathway Leading to NF-κB and MAPKs* , 2004, Journal of Biological Chemistry.

[21]  A. Gurney,et al.  Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17* , 2003, The Journal of Biological Chemistry.

[22]  Jianjun Li,et al.  Study on Nuclear Factor-κB Activation in Skin Lesions of Systemic Lupus Eryt hematosus , 2002 .

[23]  P. Burkett,et al.  Recent Advances in Understanding NF-κB Regulation , 2002 .

[24]  D. Gladman,et al.  Systemic lupus erythematosus disease activity index 2000. , 2002, The Journal of rheumatology.

[25]  P. Dawson,et al.  Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[26]  M. Nambiar,et al.  Immune cell signaling in lupus. , 2000, Current opinion in rheumatology.

[27]  S. Busfield,et al.  Identification and gene organization of three novel members of the IL-1 family on human chromosome 2. , 2000, Genomics.

[28]  M. Doyle,et al.  Identification and Initial Characterization of Four Novel Members of the Interleukin-1 Family* , 2000, The Journal of Biological Chemistry.

[29]  D. Gladman,et al.  Accurately describing changes in disease activity in Systemic Lupus Erythematosus. , 2000, The Journal of rheumatology.

[30]  H. Pahl.  Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[31]  G. Ghosh,et al.  Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA , 1998, Nature.

[32]  Ye Dong-qing.  Review on the role of JAK/STAT signaling pathway in systemic lupus erythematosus , 2010 .

[33]  I. Sanz,et al.  Altered B cell receptor signaling in human systemic lupus erythematosus. , 2009, Autoimmunity reviews.

[34]  Zhao Hong-l.  Investigative Advancement of Nuclear Factor-κB in Dermatosis , 2007 .

[35]  Tang De-shen.  Expression and significance of NF-κB in mouse renal tissue with lupus nephritis-prone BXSB , 2005 .

[36]  K. Yoshioka,et al.  Cellular localization of inflammatory cytokines in human glomerulonephritis , 2004, Virchows Archiv.